In the US, Metaglip (glipizide/metformin systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.
US matches:
- Metaglip
Ingredient matches for Metaglip
Glipizide is reported as an ingredient of Metaglip in the following countries:
- United States
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metaglip in the following countries:
- United States
International Drug Name Search